How many insider declarations has Rubinstein Linda M filed?

Rubinstein Linda M has filed 3 public insider declarations with SEC (Form 4).

What is Rubinstein Linda M's role?

Rubinstein Linda M's reported role is not specified by the regulator across the filings.

Which companies does Rubinstein Linda M report trades for?

Rubinstein Linda M reports trades for Adverum Biotechnologies, Inc..

What is Rubinstein Linda M's declared buy vs sell volume?

Across the available history, declared buys total 136k€ and disposals 0.

← Executives ★ Sign in to follow

RL

Rubinstein Linda M

·SEC (Form 4)

Adverum Biotechnologies, Inc.

0

申报总数

0

公司

€135,877

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the detailed record of transactions filed by Rubinstein Linda M. Director active across 1 company, notably Adverum Biotechnologies, Inc.. Aggregated, 3 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €136k. Activity tracked since 7 June 2023. The latest transaction was disclosed on 9 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.

Companies and markets linked to Rubinstein Linda M

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Adverum Biotechnologies, Inc. (US)

申报3 总计

◇

Rubinstein Linda M

CHIEF FINANCIAL OFFICER高管2025年12月9日Adverum Biotechnologies, Inc.

US$204,75025SEC ↗

48,750 股@ US$4.2056.4% 占其流量Common StockSEC:0001321937-25-000005:0

◆

Rubinstein Linda M

CHIEF FINANCIAL OFFICER高管2025年2月25日Adverum Biotechnologies, Inc.

0SEC ↗

8,125 股0Common StockSEC:0001415889-25-005835:0

▲

Rubinstein Linda M

Chief Financial Officer高管2023年6月7日Adverum Biotechnologies, Inc.

US$145,49031SEC ↗

100,000 股@ US$1.4549100.0% 占其流量Common StockSEC:0001209191-23-035862:0

标准退出：2023年9月5日 (T+90)

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

RL

Rubinstein Linda M

·SEC (Form 4)

Adverum Biotechnologies, Inc.

0

申报总数

0

公司

€135,877

▲ 买入（1 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

1

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the detailed record of transactions filed by Rubinstein Linda M. Director active across 1 company, notably Adverum Biotechnologies, Inc.. Aggregated, 3 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €136k. Activity tracked since 7 June 2023. The latest transaction was disclosed on 9 December 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.